T Kamada Selected Research

T Kamada Research Topics

Disease

6	Infections 06/2005 - 02/2000
4	Neoplasms (Cancer) 01/2020 - 09/2000
4	Gastritis 06/2005 - 03/2000
3	Atrophy 06/2005 - 03/2002
3	Atrophic Gastritis 07/2003 - 03/2002
2	Chordoma 10/2013 - 12/2011
2	Duodenogastric Reflux 06/2012 - 01/2001
2	Carcinoma (Carcinomatosis) 05/2006 - 02/2000
2	Peptic Ulcer (Peptic Ulcers) 06/2005 - 06/2005
2	Hypertension (High Blood Pressure) 10/2001 - 02/2000
2	Unstable Angina 09/2001 - 02/2001
2	Chronic Hepatitis C 05/2001 - 09/2000
2	Acute Coronary Syndrome 02/2001 - 02/2001
2	Essential Hypertension 02/2000 - 01/2000
1	Melanoma (Melanoma, Malignant) 10/2017
1	Neoplasm Metastasis (Metastasis) 10/2017
1	Uterine Neoplasms (Uterine Cancer) 12/2015
1	Diarrhea 01/2015
1	Irritable Bowel Syndrome (Syndrome, Irritable Bowel) 01/2015
1	Prostatic Neoplasms (Prostate Cancer) 05/2014
1	Stomach Neoplasms (Stomach Cancer) 10/2013
1	Sarcoma (Soft Tissue Sarcoma) 10/2013
1	Dyspepsia (Indigestion) 06/2012
1	Hemorrhage 06/2005
1	Duodenal Ulcer (Curling's Ulcer) 01/2005
1	Hypercholesterolemia 01/2005
1	Obesity 01/2005
1	Stomach Ulcer (Gastric Ulcer) 01/2005
1	Hypoxia (Hypoxemia) 07/2003
1	Bone Marrow Failure Disorders 04/2003
1	Metaplasia 08/2002
1	Leg Ulcer 01/2002
1	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 12/2001
1	Stable Angina 09/2001
1	Cardiovascular Diseases (Cardiovascular Disease) 09/2001
1	Angina Pectoris 09/2001
1	Peptic Esophagitis (Reflux Esophagitis) 05/2001
1	Cryptosporidiosis 03/2001
1	Waterborne Diseases 03/2001
1	Myocardial Ischemia (Ischemic Heart Diseases) 02/2001
1	Rupture 02/2001
1	Myocardial Infarction 02/2001
1	Spasm (Spasms) 11/2000
1	Muscle Spasticity (Spastic) 11/2000
1	Hepatocellular Carcinoma (Hepatoma) 09/2000

Drug/Important Bio-Agent (IBA)

4	Pepsinogen A (Pepsinogen)IBA 10/2013 - 03/2002
4	AcidsIBA 06/2005 - 03/2000
2	Biomarkers (Surrogate Marker)IBA 01/2015 - 10/2013
2	AntralIBA 06/2012 - 01/2001
2	Famotidine (Pepcid)FDA LinkGeneric 06/2005 - 06/2005
2	Proteins (Proteins, Gene)FDA Link 07/2003 - 02/2001
2	Vasoconstrictor AgentsIBA 10/2001 - 11/2000
2	Interferon-alpha (Interferon Alfa)IBA 05/2001 - 09/2000
2	SaltsIBA 02/2000 - 01/2000
1	Biological ProductsIBA 01/2020
1	Methionine (L-Methionine)FDA Link 10/2017
1	A-factor (Streptomyces)IBA 10/2017
1	ramosetron (Nasea)IBA 01/2015
1	Serotonin (5 Hydroxytryptamine)IBA 01/2015
1	MicroRNAs (MicroRNA)IBA 10/2013
1	TESIBA 10/2013
1	Z 338IBA 06/2012
1	Omeprazole (Prilosec)FDA LinkGeneric 06/2005
1	Histamine Receptors (Histamine Receptor)IBA 06/2005
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 07/2003
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 04/2003
1	Methylene Blue (Methylthioninium Chloride)FDA Link 08/2002
1	Coloring Agents (Dyes)IBA 08/2002
1	AntibodiesIBA 03/2002
1	Ointments (Pastes)IBA 01/2002
1	Hydroxyurea (Hydrea)FDA LinkGeneric 01/2002
1	tocoretinate (tretinoin tocoferil)IBA 01/2002
1	Fatty Acids (Saturated Fatty Acids)IBA 12/2001
1	Hormones (Hormone)IBA 10/2001
1	F(6) ATPaseIBA 10/2001
1	iodofiltic acidIBA 09/2001
1	Iodine-123IBA 09/2001
1	pentadecanoic acidIBA 09/2001
1	ThalliumIBA 09/2001
1	Interferon-gamma (Interferon, gamma)IBA 05/2001
1	AmmoniaIBA 05/2001
1	Drinking WaterIBA 03/2001
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 02/2001
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 02/2001
1	Peptide Hydrolases (Proteases)FDA Link 02/2001
1	Tissue Inhibitor of Metalloproteinase-1IBA 02/2001
1	Matrix Metalloproteinase 9 (Gelatinase B)IBA 02/2001
1	UreaseIBA 01/2001
1	Type C PhospholipasesIBA 11/2000
1	2,5-dichloro-4-bromophenol (B 2)IBA 09/2000
1	Transaminases (Aminotransferases)IBA 09/2000
1	EndotoxinsIBA 09/2000
1	InterferonsIBA 09/2000

Therapy/Procedure

8	Therapeutics 06/2005 - 06/2000
6	Heavy Ion Radiotherapy 10/2017 - 12/2011
1	Intravenous Infusions 06/2005
1	Stem Cell Transplantation 04/2003
1	Debridement 01/2002
1	Secondary Prevention 02/2001
1	Myocutaneous Flap 09/2000